Charles River Laboratories (CRL) Tops Q4 EPS by 29c, Revenues Beat; Offers FY21 EPS Guidance Above Consensus
Go back to Charles River Laboratories (CRL) Tops Q4 EPS by 29c, Revenues Beat; Offers FY21 EPS Guidance Above Consensus| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 180.18 -4.82 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $185.00 | 52 Week High | $89.18 | |||
| Open | $183.51 | 52 Week Low | $65.70 | |||
| Day High | $186.30 | P/E | 83.80 | |||
| Day Low | $179.70 | EPS | $2.15 | |||
| Volume | 286,503 | |||||
